Scientists have uncovered a mechanism in the brain that explains how drugs like methamphetamine and PCP impair cognitive ...

Male and female mice process threats using different brain circuits, even though their behavioral responses are similar.

Phase 2 trial is designed to evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a ...

A groundbreaking study published in The Journal of Neuroscience uncovers alarming insights into how obesity disrupts male ...

It plays a role in cognition, memory, and mood. Magnesium interacts with the N-methyl-d-aspartate (NMDA) receptor, which is necessary for glutamatergic excitatory signaling. Hypomagnesaemia, or ...

A tailored cocktail of genes can reprogram a subset of progenitors to no longer produce glial cells and instead develop into neurons involved in motor control.

Challenging movement can improve anxiety more effectively by recruiting the hypothalamic-cerebellar orexinergic circuit which more strongly activates the cerebello-amygdalar glutamatergic ...

Schizophrenia is thought to involve a dysfunction of glutamatergic and GABAergic signaling in the prefrontal cortex, but how these systems interact in the disease has been unclear. Now ketamine ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Half Year Results Newron presents H1 2024 results and provides business update 19.09.2024 / 07:00 CET/CEST The issuer is solely responsible ...

Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.

In this study, we investigated the neuronal activity of the dentate gyrus (DG) with electrophysiological and optical imaging tools during sleep-wake cycles. We found that the activity of major ...

Newron today announces its financial and operational results for the half year ended June 30, 2024, and provides an update on ...